Thrombotic complications in essential thrombocythemia (ET): Clinical facts and biochemical riddles
- 1 May 2006
- journal article
- review article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 36 (3) , 379-384
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosisBritish Journal of Haematology, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemiaThe American Journal of Medicine, 2004
- Propensity for hemorrhage and thrombosis in chronic myeloproliferative disordersSeminars in Hematology, 2004
- ThrombocytosisNew England Journal of Medicine, 2004
- Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patientsCancer, 1991
- Hemostatic complications in young patients with essential thrombocythemiaThe American Journal of Medicine, 1990
- Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.Journal of Clinical Oncology, 1990
- Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: Relationship to platelet number and functionEuropean Journal of Cancer and Clinical Oncology, 1983
- Über Einen Fall von Hochgradiger ThrombocytenvermehrungJournal of Molecular Medicine, 1930